Education Resources
Learn about the do's and don'ts of the hemp and CBD industry.
Litigation Tracker
Track the status of cases that matter the most
Regulatory
HHS to DEA: Marijuana Should Be Schedule III – What This Means for The Cannabis IndustryTwo hemp-derived CBD bills are re-introduced despite FDA’s call for a different legislative fixFDA seems willing to make room for a drug ingredient in a supplement, but what does that mean for CBD? NAC and the Drug Exclusion Clause of 201(ff)
What's New
HHS to DEA: Marijuana Should Be Schedule III – What This Means for The Cannabis IndustryTwo hemp-derived CBD bills are re-introduced despite FDA’s call for a different legislative fixFDA seems willing to make room for a drug ingredient in a supplement, but what does that mean for CBD? NAC and the Drug Exclusion Clause of 201(ff)